NEUROPEPTIDERGIC MEDIATION OF THE ACUTE PHASE REACTION
急性期反应的神经肽能介导
基本信息
- 批准号:3477339
- 负责人:
- 金额:$ 7.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1988
- 资助国家:美国
- 起止时间:1988-04-01 至 1993-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The response of an organism to infection, known as the acute
phase reaction (APR), appears to be mediated primarily by soluble
products of mononuclear phagocytes. These soluble mediators or
endogenous pyrogens (EPs), such as interleukin-1 (IL-1), may act
within the central nervous system (CNS) to mediate many of the
changes associated with the APR. The anterior, preoptic area of
the hypothalamus (AH/POA) represents one area of the CNS that
is known to be sensitive to the EPs and believed to be part of the
circuitry involved in the development of the thermal component
of the APR.
A series of experiments are proposed to elucidate the means by
which central mechanisms influence fever and the APR. First,
other sites in the CNS (e.g., the ventral septal area or VSA and
the organum vasculosum lamina terminalis or OVLT), will be
evaluated for their reactivity to the EPs and their involvement in
the evocation of the APR. Second, the efficacy of perfusing
antipyretics, both exogenous and endogenous (e.g., arginine
vasopressin or AVP), directly into these sites in suppressing the
thermal and nonthermal components of the APR will be examined.
Third, the AVP-induced antagonism of the APR will be
characterized using both in vitro and in vivo techniques. Fourth,
the effects of electrical stimulation of cell bodies containing AVP
on the pathogenesis of fever and the APR will be examined.
Fifth, the role of the amines in the evocation and/or suppression
of the APR will be determined. Utilizing a microperfusion
technique, it will be possible to determine the role of EPs, brain
peptides and other putative mediators in the pathogenesis of fever
and the APR.
The long term goals are to elucidate the mechanism by which
pyrogens act to elicit the thermal and nonthermal components of
the APR and to identify the means by which the CNS elaborates
endogenous antipyretics to prevent the deleterious effects of
hyperpyrexias. This information should prove useful in
determining the manner in which the CNS directly influences
immune, physiologic and hematologic functions during infection.
As a result, it may be possible to develop specific therapeutic
agents to reduce life-threatening pyrexic responses without
precluding the potentially beneficial aspects of fever.
机体对感染的反应,称为急性反应
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM D RUWE其他文献
WILLIAM D RUWE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM D RUWE', 18)}}的其他基金
NEUROPEPTIDERGIC MEDIATION OF THE ACUTE PHASE REACTION
急性期反应的神经肽能介导
- 批准号:
3477337 - 财政年份:1988
- 资助金额:
$ 7.23万 - 项目类别:
NEUROPEPTIDERGIC MEDIATION OF THE ACUTE PHASE REACTION
急性期反应的神经肽能介导
- 批准号:
3477338 - 财政年份:1988
- 资助金额:
$ 7.23万 - 项目类别:
NEUROPEPTIDERGIC MEDIATION OF THE ACUTE PHASE REACTION
急性期反应的神经肽能介导
- 批准号:
3477340 - 财政年份:1988
- 资助金额:
$ 7.23万 - 项目类别:
NEUROPEPTIDERGIC MEDIATION OF THE ACUTE PHASE REACTION
急性期反应的神经肽能介导
- 批准号:
3477341 - 财政年份:1988
- 资助金额:
$ 7.23万 - 项目类别:
相似海外基金
Aspirin before Exercise: Antipyretic pretreatment to reduce exercise-induced overheating and exhaustion in RRMS patients
运动前服用阿司匹林:退热预处理可减少 RRMS 患者运动引起的过热和疲惫
- 批准号:
9908128 - 财政年份:2019
- 资助金额:
$ 7.23万 - 项目类别:
Aggressive Antipyretics in CNS Malaria: A Randomized-Controlled Trial Assessing Antipyretic Efficacy and Parasite Clearance
中枢神经系统疟疾中的强力退热药:评估退热功效和寄生虫清除的随机对照试验
- 批准号:
9923006 - 财政年份:2017
- 资助金额:
$ 7.23万 - 项目类别:
Aggressive Antipyretics in CNS Malaria: A Randomized-Controlled Trial Assessing Antipyretic Efficacy and Parasite Clearance
中枢神经系统疟疾中的强力退热药:评估退热功效和寄生虫清除的随机对照试验
- 批准号:
10179500 - 财政年份:2017
- 资助金额:
$ 7.23万 - 项目类别:
Investigation on the mechanism underlying antipyretic effect of atrial natriuretic peptide within the brain
心房钠尿肽脑内解热作用机制研究
- 批准号:
19590225 - 财政年份:2007
- 资助金额:
$ 7.23万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigation on atrial natriuretic peptide as an endogenous antipyretic
心房钠尿肽作为内源性解热药的研究
- 批准号:
17590204 - 财政年份:2005
- 资助金额:
$ 7.23万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanism of action of a new endogenous antipyretic
新型内源性退热药的作用机制
- 批准号:
11670068 - 财政年份:1999
- 资助金额:
$ 7.23万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
ANTIPYRETIC EFFICACY AND SAFETY OF CHEWABLE VS LIQUID IBUPROFEN
咀嚼片与液体布洛芬的退热功效和安全性
- 批准号:
6279328 - 财政年份:1997
- 资助金额:
$ 7.23万 - 项目类别:
ANTIPYRETIC EFFECTS IN PATIENTS WITH TUMOR-RELATED FEVER
肿瘤相关发热患者的退热作用
- 批准号:
3947038 - 财政年份:
- 资助金额:
$ 7.23万 - 项目类别:
ANTIPYRETIC EFFECTIVENESS AND SAFETY OF ACETAMINOPHEN IN FERBILE CHILDREN
对乙酰氨基酚对多产儿的退热效果和安全性
- 批准号:
4700051 - 财政年份:
- 资助金额:
$ 7.23万 - 项目类别:
ANTIPYRETIC EFFICACY AND SAFETY OF CHEWABLE VS LIQUID IBUPROFEN
咀嚼片与液体布洛芬的退热功效和安全性
- 批准号:
6118133 - 财政年份:
- 资助金额:
$ 7.23万 - 项目类别: